Analyst stock forecast
Helus Pharma Forecast: $40.64 Analyst Target
Direct answer
Helus Pharma's average price target is $40.64.
The target implies +358.7% from the recorded current price, and the consensus rating is none.
The low target implies +67.8%, the high target implies +679.1%, and the range spans 611.3% of the current price.
Forecast evidence checked November 13, 2026.
Get free Helus Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $8.86
- Average price target
- $40.64
- High price target
- $69.03
- Low price target
- $14.87
- Low target gap
- +67.8%
- Target upside
- +358.7%
- High target gap
- +679.1%
- Target range width
- 611.3%
- Consensus rating
- none
- Analysts
- 10
- Evidence date
- November 13, 2026
- Valid through
- November 20, 2026
Explore related company data
Read the frequently asked questions.
What is Helus Pharma's average price target?
Helus Pharma's verified average price target is $40.64. The target range is $14.87 to $69.03.
How far are Helus Pharma's low and high targets from the recorded price?
The low target implies +67.8%, while the high target implies +679.1%.
How many analysts are included in Helus Pharma's consensus?
The verified consensus includes 10 analysts.
How is Helus Pharma's target upside or downside calculated?
The average target of $40.64 is divided by the recorded price of $8.86, then one is subtracted to produce +358.7%. This does not guarantee a future return.
When was Helus Pharma's analyst forecast verified?
The data was verified on 2026-11-13. The dataset is valid through 2026-11-20.